New clinical trial (completed), posted 18 Nov 2026: Artificial Intelligence-Based Eye Disease Diagnosis in Hospital Eye Clinics.
Details
As recorded: New clinical trial (completed), posted 18 Nov 2026: Artificial Intelligence-Based Eye Disease Diagnosis in Hospital Eye Clinics
Link: https://clinicaltrials.gov/study/NCT07945366. Source: ClinicalTrials.gov, trials matching "glaucoma treatment". A registered trial is a plan, not a result.
New clinical trial (not yet recruiting), posted 18 Nov 2026: Effect of a Nicotinamide Riboside-Based Dietary Supplement on Retinal Function in Glaucoma (BRIGHT).
Details
As recorded: New clinical trial (not yet recruiting), posted 18 Nov 2026: Effect of a Nicotinamide Riboside-Based Dietary Supplement on Retinal Function in Glaucoma (BRIGHT)
Link: https://clinicaltrials.gov/study/NCT07945340. Source: ClinicalTrials.gov, trials matching "glaucoma treatment". A registered trial is a plan, not a result.
New preprint on medRxiv, 13 Nov 2026: Clinical outcomes of bio-interventional cyclodialysis with one or multiple allogeneic reinforcements: a multicenter real-world evidence study.
Details
As recorded: New preprint on medRxiv, 13 Nov 2026: Clinical outcomes of bio-interventional cyclodialysis with one or multiple allogeneic reinforcements: a multicenter real-world evidence study
Link: https://doi.org/10.64898/2026.11.12.26367929. Source: Europe PMC, preprints posted in the last 30 days for "glaucoma treatment". A preprint has not been peer reviewed yet.
New preprint on medRxiv, 13 Nov 2026: Uveoscleral Outflow Enhancement as a Complementary Bio-intervention after Failed Prior Trabecular Outflow Treatment: 12-Month Outcomes of Allograft-reinforced Cyclodialysis in….
Details
As recorded: New preprint on medRxiv, 13 Nov 2026: Uveoscleral Outflow Enhancement as a Complementary Bio-intervention after Failed Prior Trabecular Outflow Treatment: 12-Month Outcomes of Allograft-reinforced Cyclodialysis in…
Link: https://doi.org/10.64898/2026.11.12.26367933. Source: Europe PMC, preprints posted in the last 30 days for "glaucoma treatment". A preprint has not been peer reviewed yet.
New preprint on Preprints.org, 11 Nov 2026: Laser Iris Depigmentation for Eye-Color Change: Stromal Pigment Biology, Anterior-Segment Response, and Longitudinal Clinical Assessment.
Details
As recorded: New preprint on Preprints.org, 11 Nov 2026: Laser Iris Depigmentation for Eye-Color Change: Stromal Pigment Biology, Anterior-Segment Response, and Longitudinal Clinical Assessment
Link: https://doi.org/10.20944/preprints202611.1201.v1. Source: Europe PMC, preprints posted in the last 30 days for "glaucoma treatment". A preprint has not been peer reviewed yet.
New clinical trial (stopped early), posted 10 Nov 2026: Targeted Minimally-Invasive Glaucoma Surgery.
Details
As recorded: New clinical trial (stopped early), posted 10 Nov 2026: Targeted Minimally-Invasive Glaucoma Surgery
Link: https://clinicaltrials.gov/study/NCT07927803. Source: ClinicalTrials.gov, trials matching "glaucoma treatment". A registered trial is a plan, not a result.
New paper in Electrophoresis, 4 Nov 2026: Exploring Elimination Profiles and Metabolite Patterns of Brinzolamide and Dorzolamide After Transdermal Exposure for Doping Control Purposes.
Details
As recorded: New paper in Electrophoresis, 4 Nov 2026: Exploring Elimination Profiles and Metabolite Patterns of Brinzolamide and Dorzolamide After Transdermal Exposure for Doping Control Purposes
Link: https://pubmed.ncbi.nlm.nih.gov/42978470/. Source: PubMed (NCBI), papers listed in the last 30 days for "glaucoma treatment". The title is the authors' own; one paper is one result, not settled science.
New clinical trial (phase 2, recruiting), posted 3 Nov 2026: A Phase 2a Study Comparing the Efficacy, Safety and Tolerability of Pregabalin Eye Drops Comparing With Timolol Eye Drops in Adults With Glaucoma or….
Details
As recorded: New clinical trial (phase 2, recruiting), posted 3 Nov 2026: A Phase 2a Study Comparing the Efficacy, Safety and Tolerability of Pregabalin Eye Drops Comparing With Timolol Eye Drops in Adults With Glaucoma or…
Link: https://clinicaltrials.gov/study/NCT07913074. Source: ClinicalTrials.gov, trials matching "glaucoma treatment". A registered trial is a plan, not a result.
New clinical trial (recruiting), posted 2 Nov 2026: Effects of Balance Training in Individuals With Glaucoma.
Details
As recorded: New clinical trial (recruiting), posted 2 Nov 2026: Effects of Balance Training in Individuals With Glaucoma
Link: https://clinicaltrials.gov/study/NCT07910955. Source: ClinicalTrials.gov, trials matching "glaucoma treatment". A registered trial is a plan, not a result.
New preprint on HRB Open Res, 28 Oct 2026: Barriers and Enablers to Medication Adherence & Compliance in Glaucoma – A Scoping Review Protocol.
Details
As recorded: New preprint on HRB Open Res, 28 Oct 2026: Barriers and Enablers to Medication Adherence & Compliance in Glaucoma – A Scoping Review Protocol
Link: https://doi.org/10.12688/hrbopenres.14405.2. Source: Europe PMC, preprints posted in the last 30 days for "glaucoma treatment". A preprint has not been peer reviewed yet.
each new paper on PubMed, with the journal, the date and the link
each new clinical trial, and a line when a trial's status changes
new preprints (not yet peer reviewed) from Europe PMC
How often
Every 12 hr, run by Coinjure with the Discoveries on a topic template, 38 runs so far.
Method
Twice a day Coinjure asks PubMed, ClinicalTrials.gov and Europe PMC for new research on "glaucoma treatment" and records each new paper, preprint or clinical trial once, with the journal or trial phase, the date and the link, plus a line when a trial's status changes. Titles are the authors' own; one paper is one result, not settled science, and a preprint is not yet peer reviewed.
Running since
Oct 31, 2026, 14 findings on the record.
Never edited
Every finding is hashed when it lands and chained to the one before it, so any later change would show. Each finding's page says how to check it.
Build on this
Turn this into something
This knowledge is open to everyone. Use it to make something people need.